Placenta targeting nanoparticles carrying insulin-like growth factor 2 (IGF2) improved fetal weight in a model of fetal growth restriction [113] and a selective delivery of nanoparticle carrying nitric oxide releasing drug to uteroplacental vasculature rescued impaired placental perfusion [114]. Here, IGF2 is linked to fetal growth restriction.